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The effects of intravenous procainamide (n = 30) or pre-
potentate (n = 25) were evaluated in 55 patients with acute
.trial fibrillation and the Wolff-Pi rkinson-White syn-
drome. All patients received either procainamide (12 to 15
mg)kg body weight) or propafenone (I to 2 mglkg) during
sustained (>10 min) atria) fibrillation or after termination
of nonsustatned atria) fibrillation. Termination of atrtut
fibrillation was attributed to a drug if it occurred -15 min
after infusion . Measurements included mean cycle length of
fibritlatory electrograms (mean AA interval) as measured
at the high right atrium and shortest RR Interval between
pre-excited cycles during atriai fibrillation .
Atrial fibrillation terminated more frequently after pro-
cainamide administration (65%) than after propaenone
(46%), although this difference was not significant . Pro-
eaiuamide prolonged the shortest pre-excited RR Interval
(228 ± 41 to 339 ± 23 ms, p = 0.0001) as did propafenone
(215 ± 40 to 415 ± 198 ms, p = 0.0001) and the magnitude
of increase was greater for propofenone (p = 0,048) .
The class 1 antiarrhythmic drugs have been recommended
for the short-term therapy of atrial fibrillation in patients
with the Wo10=Parkinson-White syndrome in the absence of
an urgent requirement for cardioversion (1-4). We studied
the relative efficacy of intravenous procainamide, a class la
anliarrhythmic agent, versus propafenone, a class Ic agent,
in both slowing the ventricular response and terminating
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Patients with sustained atrial fibrillation had shorter mean
AA intervals than did their counterparts with nonsustained
.trial fibrillation (123 3 25 versus 186 = 35 ms, p =
0 .0001). Termination of sustained atria) fibrillation by
either drug was accompanied by prolongation of the mean
AA interval but not necessarily by The shortest pre-excited
RR Interval
. Termination ofatrfal fibrillation was heralded
by a 68% Increase in the main AA interval after procain-
amide administration compared with a 30% increase when
the arrhythmia persisted . For propitiating the increases
were 90% and 68%, respectively .
These data suggest that intravenous propafenone is
superior to procainemide in immediately slowing the ven-
tricular response during atria) fibrillation In patients with
the Wol&Parkinsmr-White syndrome, although procalna-
mide may be more effective In terminating the arrhythmia .
Termination of atrial fibrillation by either drug is heralded
by prolongation of the cycle length of fibrillalory waves.
(J Am Colt Cordial 1990;16:1408-14)
sustained trial
fib
. illaton in the Wolff-Parkinson-White
syndrome.
Study patients. There were 42 mate and 13 female pa-
tients aged 13 to 69 years (mean 32 :~ 13), all with antero-
grade pre-excitation on the surface electrocardiogram
(ECO)
. The majority (44 of 55) had symptomatic clinical
tachycardia and the remainder were evaluated as part of an
ongoing natural history study of the asymptomatic Wolff
Parkinson-White pattern (5) . Associated cardiac disease in
the group included Ebstein's anomaly (n =
I),
mitral valve
prolapse (n = 1) and coronary artery disease (n = 2). Clinical
atria) fibrillation had been documented in 17 patients before
the study and I patient had been resuscitated from cardiac
arrest, No patient had significant atral enlargement as
assessed echocardiographically .
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Electrophysiotogic study . All patients underwent electro-
physiologic study in the nonsedated . postahsorptive state .
Written and verbal informed consent was obtained in accor-
dance with the ethical guidelines at the University of West
ern Ontario . All antiarrhytitmic agents were discontinued at
least five half-lives before study .
The method of study 'n our laboratory has been described
(6). Briefly, three quadripolar catheters with interelectrode
distances of l, 5 and 10 mm were positioned in the high right
atrium, right ventricular apex and coronary sinus, respec-
tively. A tripolar catheter with an interelectrode distance of
10 mm was used to record the His bundle electrogram .
Patients with asvmotomatic Wolff-Parkinson-White syn-
drome did not have a coronary sinus catheter inserted
routinely .
Bipolar intracardiac electrograms (50 to 500 Hz) here
recorded at the high right atrium, right ventricular apex and
at the His bundle. Unipolar electrograms (0 .5 to I kHz) were
recorded at the coronary sinus . These intracardiac electro-
grams and surface ECG leads 1, II, 111, V, and V 6 were
simultaneously displayed on a multichannel oscilloscope and
also recorded on paper (speed 100 mm/s) by means of a 16
channel Siemens Mingogmph
. Atrial and ventricular stimu-
lation were performed at twice diastolic threshold with a
pulse width of 2 ms and included incremental atria) and
ventricular pacing and extrastimulus testing at multiple cycle
lengths. Atrial fibrillation was routinely induced by rapid
aerial pacing (cycle length 50 to 200 ms ; pulse width 2 to
6 ms) if it did not occur during the course of the study . The
shortest RR interval between two consecutive pre-excited
cycles during atrial fibrillation, the average RR interval and
the mean AA interval at the high right atria[ electrogram
were measured over at least a I min period of stable atria]
fibrillation (7) .
The atria) activity recorded at the high right
atrium was acceptable for measurement if discrete electro-
grams were separated by definite isoelectric segments or if
only minimal undulations of the baseline were observed
between distinct eleetrograms (Fig . I). The peak of each
successive electrogram was visually identified and touched
with a digitizing pen while a computer calculated the beat to
beat (peak to peak) cycle length in milliseconds. Previous
reports (8,9) have documented the accuracy and validity of
this form of measurement.
Drug infusion. Patients with sustained atrial fibrillation
(?10 min) (n = 45) were given either propafenone (n = 22) or
procainamide (n = 23) . Procainamide was given intrave-
nously at a dose of 12 to 15 mg/kg body weight at a rate of
100 mg every 1 to 2 min ; up to I to 2 mg/kg of propafenone
was given over 10 min. The infusion was discontinued when
atrial fibrillation terminated or when the maximal dose was
given . Patients with nonsustaincd atrial fibrillation (n = 10)
also received drug infusions-either propafenone (n = 3) or
procainamide (n = 7). In this group drug was infused as for
patients with sustained atrial fibrillation during sinus rhythm,
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Figu-e 1 . Effects of intravenous procainamide in a representative
patient. A . Control record . The fibrillatory activity is rapid and
disorganized and the mean cycle length is approximated by measur-
ing mom discrete detecf,ns separated by relatively isoelectric
segments in the high right aerial (HRA) electrogram (arrows) . B,
Record approximately 5 min after drag infusion demonstrates a
persistence of pre-excitation . However, there is a marked organiza-
tion of the aerial fibrillatery activity with clearly measurable elec
trograms at a longer cycle length than in the control record
. C,
Further slowing of the fibrillatory cycle length several minutes late
before reversion to normal sinus rhythm (arrow)
. 1, V, = standard
surface electrocardiographic leads.
and atrial fibrillation was reinduced. This group was used
only to assess drug effect on shortest RR, average RR and
mean AA intervals.
Definitions. Atria) fibrillation was defined as sustained
only if it persisted for >10 min
. Termination of atrial
fibrillation was considered attributable to a drug only if it
occurred :515 min after drug infusion, Later terminations of
this arrhythmia were classified as drug failures for the
purpose of this study
.
Statistical analysis. Data are presented as mean values
I SD. The Student's t test was used to determine the
significance between two continuous variables
. Analysis of
variance with covariance was used to compare changes in
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'Some patients had multiple accessory pathways. F = female : M = male.
mean AA and shortest RR intervals, For discrete end points,
chi-square analysis was used to determine statistical signif-
icance . For all these analyses statistical significance was
present when the p value was <0
.05
.
Results
Comparison of the two treatment groups (Table 1) . Thirty
patients received intravenous procainamide and 25 received
propafenone . Patients who received procainamide were sim-
ilar to those who were given propafenone with respect to
age, gender and accessory pathway location fn addition, the
shortest pre-excited RR intervals were similar in the patients
receiving procainamide and those receiving propafenone
(231 ± 43 versus 216 ± 42 ms, p = NS) . There was no change
in mean arterial blood pressure before and after administra-
tion of procainamide (83 ± 14 versus 85 ± f0 mm Hg) or
propafenone (87 ± 18 versus 86 t 14 mm Hg), One patient in
each group had a proarrhythmic response, developing atria)
flatter with 1 :1 atrioventricular (AV) conduction associated
with hypotension that required cardioversion. A single pa-
ticnl is the propafenone group developed a transient rash
without other associated symptoms .
SitSfained (n = 45)
versus nonsustained (n = 10) atria)
fibrillation
. Patients with self-terminating atrial fibrillation
were similar to patients with sustained atrial fibrillation with
respect to age (36 ± l6 versus 30 t 12 years, p = 0 .15) and
shortest RR interval during atria) fibrillation (236 t 48 versus
223 ± 42 ms, p = 0.04) . Thirty-five percent of patients with
sustained atrial fibrillation had documented clinical atrial
fibrillation compared with 10% of patients with nonsustained
atria] fibrillation (p = 0 .24). Patients with self-terminating
atria) fibrillation had longer mean AA intervals during atria)
fibrillation than did their counterparts with sustained aerial
fibrillation (186 ± 35 versus 123 ± 25 ms, p
- 0 .0001) (Fig.
2) .
Effects on ventricular response during otrial fibrillation.
The initial shortest pre-excited RR interval in the group with
sustained atrial fibrillation was similar in patients receiving
propafenone (231 `_ 43 ms
. Is = 22) en put, .ainamide (215 ±
42 Ins, n = 23) (p = 0 .20) . The shortest RR interval could be
compared before and after drug infusion in 21 patients in
50	
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Figure 2 . Comparison of baseline mean AA intervals during atrial
fihrillatian (AF) between patients with sustained and nonsustained
arrhythmia
. The mean AA interval is significantly shorter in patients
with sustained attic! 6brilladnn .
each group (Fig, 3)
. The mean shortest RR interval increased
significantly with each drug
; 228
t
41 to
339 t 123 ms for
procainamide (p = 0 .001) and 215 t 40 to 415 1.98 ms for
propafenone (p = OA001). The relative increase in shortest
pre-excited RR interval produced by propafenone was
greater than that produced by procaiaamide (p =0 .048). The
average RR interval during atrial fibrillation was increased
by propafenone (330 ± 67 to 492 ± 157 ms, p = 0 .0001) and
also by procainamide (358 t 79 to 433 t 85 ms, p = 0.0012)
.
Termination of atria) nlrrtilatton . Termination of atria)
fibrillation by either drug was independent of the initial
pre-excited shortest RR interval
. For procainamide the
shortest RR interval of patients who had atrial fibrillation
terminated was 229 t 41 ms compared with 230 ± 48 ms in
those in whom atrial fibrillation persisted (p = NS) ; simi-
larly, the shortest RR interval was 223
t
52 versus 210 t 30
ms, respectively (p = NS) in patients who received pro-
pafenone . Patients given procainamide whose arrhythmia
terminated had a similar a trial effective refractory period
(cycle length 600) to that of patients whose arrhythmia was
not terminated (mean ± SD 206 * 37 versus 190 * 12, p =
0 .4),
similar aerial functional refractory period (246 t 40
versus 232 ± 12, p = 0.5) and similar PA interval (41 t IS
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Figure 3. Effect ofpropafenoneversus procainamideontheshortest
pre-excited RR interval (SRR) during atdal fibrillation . The shortest
RR interval is increased significantly with hslh drugs, although the
effect of propafenone is greater . Conversely, more patients in the
peocainamide group have termination of arrhythmia (filled circles as
opposed to open circles) .
versus 44 ± 15, p = 0.7) . Patients given propafenone whose
arrhythmia terminated had similar atria) effective refractory
periods to those of patients whose arrhythmia was not
terminated (217 ± 37 versus 198 ± 16, p = 0 .2), similar atrial
functional refractory periods (240
._ 31 versus 222 ± 22, p =
0 .2) and similar PA intervals (49 ± 14 versus 48 ± 5, p =
0 .8) . There was no correlation between fibrillatory cycle
length and effective refractory period in patients given
procainamide (r = -0.26, p = 0.4) or propafenone (r =
-0.27, p = 0.3). Procainamide tended to be more effective
(65%) than propafenone (46%) in acute termination of atdal
fibrillation, although this difference was not significant (p =
0.36) .
The cycle length of atria) fibrillation was
significantly
prolonged by both drugs, whether or not the arrhythmia waa
terminated (Fig . 4). However, the magnitude of cycle length
prolongation was greater when atrial fibrillation terminated
than when it persisted. Procainamide increased the mean AA
interval by 68% when atrial fibrillation terminated (115 s 27
to 193 ± 33 ms, p = 0 .0001) compared with an increase of
only 36% when atria] fibrillation persisted (125 ± 24 to 169 ±
300
5 .16
5=16
r'OOOOl 00001
0
Figure 4. Effect of propafenone and procainamide an mean AA
intervals. Both drugs increased AA intervals significantly in all
patients. Propafenone tended to increase the AA interval more than
procainamide but this difference was not significant .
33 ms, p = 0.017). Similarly, propafenone increased the
mean AA interval by 90% (I I I ± 35 to 214 ± 90 ms, p =
0.025) when atrial fibrillation terminated and by only 69%
when the arrhythmia persisted (132
.
19 to 222 ± 41 ms,
p = 0.0001) . For either drug, termination of atria) fibrillation
was preceded by an
organization and stowing of the atrial
rate (Fig. 1) before reversion to sinus rhythm .
Comparison of time course between change in fibrilletwy
cycle length and shortest pre-excited RR interval In atrial
fibrillation . This comparison could be made in those pa-
tients who had predominantly pre-excited QRS complexes
during atria) fibrillation that persisted for at least 10 min after
drug infusion (Fig . 5 and 6). The maximal increase in
fibrillatory cycle length peaked within 5 min in these patients
and thereafter reached a plateau
. On the other hand, the
increase in shortest pre-excited RR interval continued to
increase >_ 10 min of atria] fibrillation
.
1412
	
BOAHENE FT AL
.
ATRIAL FIBRILLATION IN WOLFF .PARKINSON-WHITE SYNDROME
500
400
N
200
100
50
N=10
ORB
or"
	I
CONTROL (EARLY I (LATE)
PROCAINAMIDE
Figure 5 . Comparison of the increases in the shortest praexcited
RR MR) and mean AA intervals (k AA) as a function
of time
(procainamide). There is . ._ significant increase in the. neap AA
interval by 5 min (EARLY) without a further substantial increase . In
contrast, the early increase in the shortest pre-excited RR interval is
not statistically significant, but the interval continues to prolong and
the difference achieves statistical significance only at ±10 min
(LATE).
Discussion
Drug effects on ventricular response in atria) fibrillation .
Earlier investigators (1-4,10,11) have described the benefi.
cial effects of the class
III and class Ic agents in the
Wolff Parkinson-White syndrome and our data further sup-
port their use for the immediate treatment of atrial fibrillation
with a rapid ventricular response associated with pre-
excitation
. Although the class Ic agent propafenone caused a
more marked slowing of the ventricular response
over the
accessory pathway, the class la agent procainamide tended
to be more successful in terminating fibrillation . This obser-
vation could be compatible with a relatively greater effect of
the class Ia agent on refractoriness than on conduction, and
others (12,13) have made similar observations in experimen-
tal atrial fibrillation in animals
. In some instances a relatively
700
goo
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Figure 6. Comparison of the change in the shortest pre-excited RR
(SRR) and mean AA intervals (R AA) as a function of time
(propafenone) . The observations are very similar to those seen with
procainamide showing an earlier increase in the mean AA intervals.
greater effect of the class Ic agent on conduction might be
expected to stabilize reentry rather than terminate it.
Observations on atria) fibrlfiatory cycle lengths. Several
observations were made on examining the mean cycle length
of fibrillatory waves as measured at the high right atria) lead.
This lead was chosen because it displayed consistently high
amplitude atria) activity that was relatively free of interfer-
ence from far field ventricular activity . First, patients with
sustained atria) fibrillation had a shorter mean cycle length of
atrial fibrillation than did patients with nonsustained arrhyth-
mia . This finding is consistent with the observation of
Allessie and coworkers (12,13), who observed that suscep-
tibility to sustained reentrant atria) arrhythmias in experi.
mental animals was related to a short wave length (the
product of functional refractory period and conduction ve-
locity) in a potential reentrant circuit
.
Intuitively, a short
functional refractory period and slow conduction velocity
would be compatible with more stable reentry, and the
shorter fibrillatory cycle length in patients with sustained
atria) fibrillation could be a further reflection of t his . in
addition, both drugs caused a slowing and organization of
atrial fibrillatory activity, as has been noted by others (8,14).
Indeed, patients with termination of arrhythmia had signifi-
cantly greater slowing of atrial fibrillation activity,
and
failure to slow significantly correlated with a failure to
500
a 400
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Figure 7. Acceleration of ventricular response during atrial fibnila-
tion after propafenone . A, High right atria) (HRA) fibrillatory (f1
activity is fine and rapid in the control state
. B, After propafenone
the ahial fibrillatory activity appears to have slowed and this is
associated with a more rapid ventricular response . RV = right
ventricular electrogram.
venom..
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servations by further study would suggest that greater atten-
tion to atrial fihrillatory activity may provide useful informa-
tion relating to the probability of sustaining atral fibrillation
and a clearer understanding of bath the beneficial and
1
undesirable effects of antiarrhythmic drugs in this arrhyth-
mia.
Finally, it is important to emphasize the advisaoility of
prompt external defibrillation for the potential occurrence of
hemodynamic deterioration during the course of medical
therapy in patients with the Wolff-Parkioson-White syn-
drome and atrial fibrillation .
Conclusions . This study has important limitations . First,
plrrebo control was not considered feasible because many of
the patients required active drug treatment for clinical rea-
sons . Thus, neither drug in this study has been shown to he
more efficacious than placebo in immediate termination of
atria) fibrillation . Second, measurement of AA intervals was
sometimes difficult when the fibrillatory activity was of small
amplitude . The development of a, more objective, computer-
assisted assessment of amplitude and rate would be useful
for further studies of this kind . Nonetheless, discr_te elec-
trogralos could generally be identified between isoelectric
intervals, especially after the beginning of the drug infusion.
Desp
ite these limitations, our observations show that
RV
A
both propafenone and procainamide are clinically useful in
the immediate management of atria) fibrillation associated
with the Wolff-Parkinson-White syndrome . Procainamide
tended to be more effective in terminating atria) fibrillation .
and propafenone was superior in slowing the ventricular
response over the accessory pathway . Both drugs may be
associated with a proarrhythmic response that results from
slowing of atria[ fibrillatory activity and relatively less pro-
longation of accessory pathway refractoriness .
terminate atria] fit .- illation . Finally, organization and slowing
of the fibrillatory activity resulted in a proarrhythmic re-
sponse in two patients (one with each drug) who experienced
a transient acceleration of the ventricular response due to 1 :1
AV conduction .
This potential proarrhythmic response may be expected
to be more prevalent for drugs that cause a more marked
slowing of fibrillatory activity relative to prolongation of
refractoriness of the accessory pathway
. The response
would also be exacerbated by the earlier slowing of the
fibrillatory cycle length before the maximal effect of the drug
on the accessory pathway is observed . The reason for an
earlier effect on atria[ fibrillatory cycle length relative to
accessory pathway refractoriness is unclear but may be
related to the frequency dependence of the class I drugs
(15-19). which could resalt in a more marked relative slow-
ing
of rapid atria] fbrllatory activity, as opposed to the
lower rate of stimulation over the accessory pathway that is
limited by concealed conduction
. Verification of these ob-
We (hank Sheila Don. for preparation of She manuscript.
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